Overview

Study of Freeze-dried Black Raspberry in Maintenance of Ulcerative Colitis

Status:
Completed

Trial end date:
2015-11-13

Target enrollment:
0

Participant gender:
All

Summary

This research study is about adding Black Raspberry powder to the treatment regimen of patients with ulcerative colitis who are currently in remission and doing well.

Phase:

Phase 1

Accepts Healthy Volunteers?

Details

Lead Sponsor:

UConn Health

Collaborator:

Medical College of Wisconsin

Criteria

Inclusion Criteria:

Adult patients (>18 years of age) with known diagnosis of ulcerative colitis who are
currently in remission on a stable dose of 5-ASA products and/or steroids (equivalent to
prednisone 20 mg or less). English speaking/reading male or female patients from all
ethnicities will be considered for the study.

Exclusion Criteria:

- Treatment with Immunomodulators and/or biologic agents, active disease flare, patients
younger than 18 years old, patients who are pregnant or trying to get pregnant, breast
feeding and those with reported history of allergy or hypersensitivity to berry
products.

Patients who are using NSAIDS will also be excluded from the study but low dose ASA (81-162
mg) is permitted if needed.